Midgard Science

iProgen

Burnaby, BC, Canada iprogen.com

From their website, Nov 2026

Work here? Claim this listing

About

iProgen is a biotechnology company based in Vancouver, British Columbia, and Burnaby, Canada. It develops antibody drug conjugate and protein delivery technologies and works with academic and industry partners on therapeutic programs. The company says it focuses on non-oncology therapeutics as well as oncology, using its Smart Antibodies platform and related payload-conjugation technologies.

Services

  • Antibody drug conjugate discovery

    Develops next-generation antibody drug conjugate approaches using Smart Antibodies and diverse payloads.

  • Protein delivery technology development

    Creates and applies intracellular and conditionally activated protein delivery technologies for therapeutic programs.

  • Antibody internalization technology licensing

    Out-licenses antibody internalization technologies for delivery applications.

  • Antibody-oligonucleotide conjugate technology licensing

    Out-licenses technologies for antibody-oligonucleotide conjugate applications.

  • Degrader antibody conjugate technology licensing

    Out-licenses modular degrader antibody conjugate technology.

  • Research collaboration

    Works with academic and industry partners to design antibody drug candidates, perform preliminary in-vitro evaluations, and advance collaborative programs.

  • Antibody and ADC assay development

    Develops assays for antibody and ADC research programs.

    Assays & in vitro testing

  • Cell line development

    Provides cell line development expertise for research and development projects.

    Cell line development

  • Recombinant protein production

    Supports recombinant protein production, including cGMP-related work and characterization.

    Protein production

Capabilities

Assays and studies
Antibodies · ADCs · Small molecules · Peptides · Oligonucleotides · In-vitro evaluations · In-vivo evaluations · Antibody assay development · ADC assay development · Preliminary in-vitro evaluations
Therapeutic areas
Oncology · Sarcopenia · Neurodegenerative · Osteoporosis · Non-oncology therapeutics

Modalities and species

Modalities
Small molecule · Antibody · ADC · Peptide · Oligonucleotide · Recombinant protein · Vaccine

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

Industries served

  • Biotech
  • Therapeutic research

Locations

Based in
Burnaby, BC, Canada
Sites
Vancouver, Canada · Burnaby, Canada
Serves
global

Contacts

Similar labs

Work here? Claim this listing